Miss Wyki Gina Pang, MD | |
22 Bramhall St, Department Of Medicine, Portland, ME 04102-3134 | |
(207) 662-0111 | |
Not Available |
Full Name | Miss Wyki Gina Pang |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 22 Bramhall St, Portland, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205248549 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 25MA10390400 (New Jersey) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Wyki Gina Pang, MD 22 Bramhall St, Department Of Medicine, Portland, ME 04102-3134 Ph: (207) 662-0111 | Miss Wyki Gina Pang, MD 22 Bramhall St, Department Of Medicine, Portland, ME 04102-3134 Ph: (207) 662-0111 |
News Archive
The World Health Organization (WHO) has labeled the double mutant B.1.617 variant — first discovered in India —a variant of concern for its high transmission rate and ability to evade immune responses. New research posted to the preprint server bioRxiv finds B.1.617 can modestly reduce neutralizing antibody responses generated from the Pfizer-BioNTech vaccine.
The Mirion Technologies Health Physics Division announced it has delivered SPIR Detect area radiation monitors to the Italian Civil Defense Authority. These highly sensitive monitors are easy to deploy and can be installed permanently in a location or used as portable radiological monitors.
Researchers at Brandeis, in collaboration with several other institutions worldwide, have pinpointed for the first time the multi-country economic costs of dengue fever, the endemic and epidemic mosquito-borne illness that is a rapidly growing public health problem in tropical and sub-tropical countries.
Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at The University of Texas MD Anderson Cancer Center.
A new study supported by the National Cancer Institute found a higher cancer risk for women with dense breasts. It's the tissue in women's breast that can differ by heredity, from more fatty to more dense tissue. Fatty tissue shows up dark on a mammogram, but fibrous or dense tissue shows up white. So do small tumors, which can make them hard to find. The study was published in the July 27 online edition of the Journal of the National Cancer Institute.
› Verified 9 days ago